For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230405:nGNE2PyfcY&default-theme=true
Thames Ventures VCT 2 plc
LEI: 21380035MV1VRYEXPR95
5 April 2023
Issue of Equity
The Directors of Thames Ventures VCT 2 plc announce allotments on 5 April 2023
of Ventures Shares of 0.1p each (“Ventures Shares”) pursuant to the
Ventures Offer for Subscription which opened on 2 November 2022 and Healthcare
Shares of 0.1p each (“Healthcare Shares”) pursuant to the Healthcare Offer
for Subscription which opened on 26 October 2022 as follows:
Shares Average issue price per share
Ventures Shares 333,929 66.00p
Healthcare Shares 1,533,714 68.34p
Application for these shares to be admitted to the Official List of the UK
Listing Authority and to trading on the London Stock Exchange's market for
listed securities will be made shortly. Dealings are expected to commence on
or around 14 April 2023.
Following these allotments, the issued share capital and total voting rights
(excluding management shares) of the Company are summarised follows:
Voting
Shares rights Voting
in issue per share rights
DSO D Shares 7,867,247 232 1,825,201,304
DP67 Ordinary Shares 11,192,136 375 4,197,051,000
Ventures Shares (excluding Mgt Shares) 53,210,344 860 45,760,895,840
Healthcare Shares (excluding Mgt Shares) 23,366,627 860 20,095,299,220
AIM Shares 2,695,803 1,146 3,089,390,238
Total Voting Rights 74,967,837,602
The Total Voting Rights of the Company shown above may be used by shareholders
as the denominator for the calculations by which they determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules